MAGNEFAR B6

This brand name is authorized in Poland

Active ingredients

The drug MAGNEFAR B6 contains a combination of these active pharmaceutical ingredients (APIs):

1 Magnesium citrate
UNII RHO26O1T9V - MAGNESIUM CITRATE
Read about Magnesium citrate
2 Pyridoxine
UNII 68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE

Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition.

Read about Pyridoxine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A12CC04 Magnesium citrate A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CC Magnesium
Discover more medicines within A12CC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100406242, 100406259

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈